RINIF yields 2.89% · JNJ yields 2.14%● Live data
📍 RINIF pulled ahead of the other in Year 1
Combined, RINIF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of RINIF + JNJ for your $10,000?
Rinnai Corporation develops, manufactures, and sells heating products in Japan, the United States, Australia, China, South Korea, and Indonesia. The company offers water heaters, including hot-water units, bath hot-water units, hot-water and heating units, gas/solar hybrid hot-water and heating systems, etc.; kitchen appliances, such as tabletop stoves, built-in-stoves, ovens, range food, dishwashers and rice cookers, etc.; and air conditioning appliances comprising fan heaters, fan-forced heaters, infrared heaters, etc. It also provides commercial-use equipment comprising grills, gas stoves and rice cookers, etc.; and living room and dressing room products, as well as others, such as clothes dryers, infrared burners and parts, etc. The company offers its products under the Rinnai brand name. The company was formerly known as Rinnai & Co. and changed its name to Rinnai Corporation in 1971. Rinnai Corporation was incorporated in 1920 and is headquartered in Nagoya, Japan.
Full RINIF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.